Contributors
Julia Kalashova: Role: ConceptualizationRole: Data curationRole: MethodologyRole: Writing – original
draft
Chenglu Yang: Role: Data curationRole: MethodologyRole: Writing – original draft
Hongmei Li: Role: Data curation
Yan Long: Role: Data curation
Duo Yu: Role: Data curation
Ting Zhang: Role: ConceptualizationRole: Data curationRole: Methodology
Xumei Liu: Role: Data curation
Namrta Choudhry: Role: Writing – review & editing
Qiong Shi: Role: ConceptualizationRole: Data curationRole: Writing – original draftRole: Writing
– review & editing
Thaddeus D. Allen:
ORCID: https://orcid.org/0000-0002-4268-3394
Role: ConceptualizationRole: Writing – original draftRole: Writing – review & editing
Amir Faisal: Role: Editor
Journal
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS One
Journal ID (publisher-id): plos
Title:
PLOS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
30
October
2023
Publication date Collection: 2023
Volume: 18
Issue: 10
Electronic Location Identifier: e0293283
Affiliations
[1
]
Division of Discovery Oncology, Chengdu Anticancer Bioscience, Chengdu, Sichuan, China
[2
]
Department of Basic Cancer Research, J. Michael Bishop Institute of Cancer Research,
Chengdu, Sichuan, China
Lahore University of Management Sciences, Syed Babar Ali School of Science and Engineering,
PAKISTAN
Author notes
Competing Interests: The J. Michael Bishop Institute of Cancer Research and Chengdu Anticancer Bioscience
LTD has filed a PCT application (PCT/CN2021/82684) that covers the compound LXY18
under this study. This does not alter our adherence to PLOS ONE policies on sharing
data and materials.
Author information
Article
Publisher ID:
PONE-D-23-20900
DOI: 10.1371/journal.pone.0293283
PMC ID: 10615259
PubMed ID: 37903144
SO-VID: b72e4022-2334-4386-85d9-4f2bab5c9fe1
Copyright © © 2023 Kalashova et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
History
Date
received
: 5
July
2023
Date
accepted
: 10
October
2023
Page count
Figures: 7,
Tables: 0,
Pages: 19
Funding
Funded by:
The J. Michael Bishop Institute of Cancer Research receives funding through an endowment
from Anticancer Bioscience, a company actively engaged in the commercial development
of cancer therapeutics
Award ID: 2016
Award Recipient
:
ORCID: https://orcid.org/0000-0002-4268-3394
Thaddeus D. Allen
The J. Michael Bishop Institute of Cancer Research receives funding through an endowment
from Anticancer Bioscience in 2016, a company actively engaged in the commercial development
of cancer therapeutics. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Categories
Subject:
Research Article
Subject:
Biology and Life Sciences
Subject:
Cell Biology
Subject:
Cell Processes
Subject:
Cell Death
Subject:
Apoptosis
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancer Treatment
Subject:
Biology and Life Sciences
Subject:
Cell Biology
Subject:
Cell Processes
Subject:
Cell Cycle and Cell Division
Subject:
Mitosis
Subject:
Biology and Life Sciences
Subject:
Cell Biology
Subject:
Chromosome Biology
Subject:
Mitosis
Subject:
Biology and Life Sciences
Subject:
Cell Biology
Subject:
Molecular Motors
Subject:
Motor Proteins
Subject:
Biology and Life Sciences
Subject:
Biochemistry
Subject:
Proteins
Subject:
Motor Proteins
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancers and Neoplasms
Subject:
Lung and Intrathoracic Tumors
Subject:
Research and analysis methods
Subject:
Biological cultures
Subject:
Cell lines
Subject:
DU145 cells
Subject:
Medicine and Health Sciences
Subject:
Oncology
Subject:
Cancer Treatment
Subject:
Cytokine Therapy
Custom metadata
